Abstract
Molecular genetics and molecular biology have produced fantastic gains in the understanding of cellular mechanisms involved in neoplasia. Clinical application of these gains, however, remains in its infancy at present. One area of intense interest is gene therapy, the treatment of patients to correct germline or acquired abnormalities in genes, including those involved in neoplasia (reviewed in reference 1). The variety of altered genes in neoplasia provides numerous potential targets for this therapeutic approach.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A.A. Gutierrez, N.R. Lemoine, K. Sikora, Gene therapy for cancer. Lancet 339: 715 (1992).
E.R. Fearon, Genetic alterations underlying colorectal tumorigenesis. Cancer Surveys 12: 119 (1992).
E.C. Fearon, and P.A. Jones, Progressing toward a molecular description of colorectal cancer development. FASEB 6: 2783 (1992).
S.R. Hamilton, Molecular genetics of colorectal carcinoma. Cancer Supplement 70: 1216 (1992).
A.K. Rustgi, D.K. Podolsky, The molecular baiss of colon cancer. Ann. Rev. Med. 43: 61 (1992).
D.J. Ahnen, Genetics of colon cancer (review). West J. Med. 154: 700 (1991).
E.R. Fearon, and B. Vogelstein, A genetic model for colorectal tumorigenesis. Cell 61: 759 (1990).
B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, M. Leppert, Y. Nakamura, R. White, A.M.M. Smiths, J. Bos, Genetic alterations during colorectal-tumor development. New Engl. J. Med. 319: 525 (1988).
C. Melani, L. Rivoltini, G. Parmiani, B. Calabretta, M.P. Colombo, Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res 51: 2897 (1991).
S.M. Powell, N. Zilz, Y. Beazer-Barclay, T. M. Bryan, S.R. Hamilton, S. N. Thibodeau, B. Vogelstein, K.W. Kinzler. APC mutations occur early during colorectal tumorigenesis. Nature 359: 235 (1992).
K.W. Kinzler, M.C. Nilbert, B. Vogelstein, T.M. Bryan, D.B. Levy, K.J. Smith, A.C. Preisinger, S.R. Hamilton, P. Hedge, A. Markham, M. Carlson, G. Joslyn, J. Groden, R. White, Y. Miki, Y. Miyoshi, I. Nishisho, Y. Nakamura. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 251: 1366 (1991).
E.R. Fearon, K.R. Cho, J.M. Nigro, S.E. Kern, J.W. Simons, J.M. Ruppert, S.R. Hamilton, A.P. Preisinger, G. Thomas, K.W. Kinzler, B. Vogelstein, Identification of a chromosome 18q gene which is altered in colorectal cancers. Science 247: 49 (1990).
S. J. Baker, E.R. Fearon, J. M. Nigro, S.R. Hamilton, A.C. Preisinger, J.M. Jessup, P. vanTuinen, D.H. Ledbetter, D.F. Barker, Y. Nakamura, R. White, B. Vogelstein. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217–221 (1989).
S. J. Baker, A.C. Preisinger, J.M. Jessup, C. Paraskeva, S. Markowitz, J.K.V. Willson, S.R. Hamilton, B. Vogelstein, p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50: 7717 (1990).
J. Cunningham, J.A. Lust, D.J. Schaid, G.D. Bren, H.A. Carpenter, E. Rizza, J.S. Kovach, S.N. Thibodeau, Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res. 52: 1974 (1992).
A.J. Levine. The p53 tumor suppressor gene and product. Cancer Surveys 12: 59 (1992).
D.P. Lane, p53, guardian of the genome. Nature 358: 15 (1992).
S.J. Ullrich, C.U. Anderson, U.E. Mercer, E. Appella, The p53 tumor suppressor protein, a modulator of cell proliferation. J. Biol. Chem. 267: 15259 (1992).
J.W. Shay, H. Werbin, W.D. Funk, W.E. Wright, Cellular and molecular advances in elucidating p53 function. Mutation Res. 277: 163 (1992).
K.W. Kinzler, M.C. Nilbert, L-K. Su, B. Vogelstein, T.M. Bryan, D.B. Levy, K.J. Smith, A.C. Preisinger, P. Hedge, D. McKechnie, R. Fimiear, A. Markham, J. Groffen, M.S. Bogusi, S.F. Altshul, A. Horii, H. Ando, Y. Miyoshi, Y. Miki, I. Nishisho. Y. Nakamura, Identification of FAP locus genes from chromosome 5q21. Science 253: 661 (1991).
I. Nishisho, Y. Nakamura, Y. Miyoshi, Y. Miki, H. Ando, A. Horii, K. Koyama, J. Utsunomiya, S. Baba, P. Hedge, A. Markham, A.J. Krush, G. Petersen, S.R. Hamilton, M.C. Nilbert, D.B. Levy, T.M. Bryan, A.C. Preisinger, K.J. Smith, L-K. Su, K.W. Kinzler, B. Vogelstein, Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665 (1991).
G. Joslyn, M. Carlson, A. Thliveris, H. Albertsen, L. Gelbert, W. Wamowitz, J. Groden, J. Stevens, L. Spirio, M. Robertson, L. Sargeant, K. Krapcho, E. Wolff, R. Burt, J.P. Hughes, J. Warrington, J. McPherson, J. Wasmuth, D. LePasliet, H. Abderrahim, D. Cohen, M. Leppert, R. White, Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66: 601 (1991).
J. Groden, A. Thliveris, W. Samowitz, M. Carlson, L. Gelbert, H. Albertsen, G. Joslyn, J. Stevens, L. Spirio, M. Robertson, L. Sargeant, K. Krapcho, E. Wolff, R. Burt, J. P. Hughes, J. Warrington, J. McPherson, J. Wasmuth, D. LePaslier, H. Abderahim, D. Cohen, M. Leppert, R. White, Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589 (1991).
M.C. Goyette, K. Cho, C.L. Fasching, D.B. Levy, K.W. Kinzler, C. Paraskeva, B. Vogelstein, E.J. Stanbridge, Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12: 1387 (1992).
K. Tanaka, M. Oshimura, R. Kikuchi, M. Seki, T. Hayashi, M. Miyaki, Suppression of tumorigenicity in human colon cancer cells by introduction of normal chromosome 5 or chromosome 18. Nature 349: 340 (1991).
S.J. Baker, S. Markowitz, E.R. Fearon, J.K. Willson, B. Vogelstein, Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912 (1990).
B. Vogelstein, E.R. Fearon, S.E. Kern, S.R. Hamilton, A.C. Preisinger, Y. Nakamura, R. White, Allelotype of colorectal caricnomas. Science 244: 207 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hamilton, S.R. (1993). Therapeutic Implications of Molecular Genetics. In: Rustum, Y.M. (eds) Novel Approaches to Selective Treatments of Human Solid Tumors. Advances in Experimental Medicine and Biology, vol 339. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2488-5_29
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2488-5_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6060-5
Online ISBN: 978-1-4615-2488-5
eBook Packages: Springer Book Archive